Rankings / Stopped for futility
Stopped for futility
Trials stopped in the last 90 days whose stated reason is a lack of effect or an interim analysis. The classification is rule-based and the original wording is shown next to it.
Last revised
Ranking
| Trial | Sponsor | Phase | Reason | Stopped |
|---|---|---|---|---|
| NCT06483789 | HB BioTech, LLC | PHASE2 | Decision to terminate study due to a lack of efficacy in this study population. There were no safety concerns identified that contributed to this decision. | 2026-09-09 |
| NCT06079190 | GlaxoSmithKline | PHASE2 | The study was terminated early due to meeting pre-specified efficacy futility criteria at planned interim analysis. | 2026-08-18 |
| NCT06029439 | Neumora Therapeutics, Inc. | PHASE3 | NMRA-335140 did not achieve the primary endpoint across three randomized controlled trials. Program discontinued due to lack of efficacy in MDD. | 2026-08-17 |
| NCT05689021 | Mayo Clinic | PHASE2 | Sponsor decided to close due to slow accrual and lack of efficacy | 2026-07-02 |
| NCT07006285 | University Hospital, Strasbourg, France | NA | Because of the negative results reported in other studies | 2026-06-30 |
| NCT05018585 | Diamyd Medical AB | PHASE3 | Stopped for futility. | 2026-06-24 |